University of Toronto researchers have found that cancer cells can enhance tumor growth by hijacking enhancer DNA normally used when tissues and organs are formed.
The gene therapy startup Lexeo Therapeutics and inflammatory disease biotech Abivax filed paperwork to go public Friday afternoon, as the pre-Thanksgiving IPO window shrinks and a
Sen. Bill Cassidy (R-LA) has called on two hospital systems to provide more information on how they use funds generated through the 340B program. Congress
The FDA on Friday unveiled a long-awaited proposed rule that aims to overhaul how the agency regulates diagnostic tests, bringing thousands of new tests under
The FDA on Friday unveiled new details around a rare disease pilot program that seeks to increase rapid, ad-hoc communications between six sponsors working on
GSK’s ViiV is returning with a second season of its award-winning podcast “Love in Gravity.” This time, instead of a different relationship story each week,
The Bloc is taking its award-winning pharma and healthcare creativity global with the addition of shops in Germany, Italy and Switzerland announced this week. Along
Madrigal Pharmaceuticals expects to raise $500 million from a stock and warrants sale, which it plans to use to prepare for the launch of resmetirom
When Sernova announced in June that five patients with type 1 diabetes with severe hyperglycemia and a complete inability to produce insulin were able to
I’m Lydia Ramsey Pflanzer, and for eight years, I’ve covered every part of the healthcare industry, diving deep into the changing way care is paid